🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsSmall molecule vs peptide GLP-1 agonists — anyone have experience? Page 2

Small molecule vs peptide GLP-1 agonists — anyone have experience?

jason_paloalto Thu, Sep 18, 2025 at 10:31 PM 33 replies 1,842 viewsPage 2 of 7
Dr.BariatricHTX
Senior Member
1,456
7,234
Feb 2024
Houston, TX
Sep 19, 2025 at 10:30 AM#6
PharmacoVig_BOS said:
Oral semaglutide is absorbed in the stomach with the help of SNAC, which locally raises pH and protects the peptide long enough to cross.

I do not accept that the fasting window is a minor inconvenience. Adherence data on daily orals with timing requirements is consistently worse than weekly injections, and a drug you take imperfectly is a lower dose than the one on the box.

Last edited: Sep 19, 2025 at 4:30 PM
21 16CarlaRPh_TPA, steph_laguna, fiona_glasgow and 18 others
Reply Quote Save Share Report
anders_CPH
Senior Member
1,567
7,234
Feb 2024
Copenhagen, DK
Sep 19, 2025 at 3:14 PM#7

One concrete data point for the thread. The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the same conditions. Nobody wants that answer and it is still the answer.

20 15MariaRD, AussieAnna, BethLabQueen and 17 others
Reply Quote Save Share Report
Dr.ReproEndo
Senior Member
1,890
8,901
Jan 2024
Scottsdale, AZ
Sep 19, 2025 at 7:58 PM#8
Dr.BariatricHTX said:
I do not accept that the fasting window is a minor inconvenience.

Adding the part of the answer the thread has not reached. There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

19 14Dr.EndoEP, GraceAZ_72, carl_compliance and 16 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
JakeSmashed95
Member
412
1,890
Aug 2024
Arkansas
Online
Sep 20, 2025 at 12:42 AM#9

Following on from BenResearch_OR — and this may be the naive question:

How much of the oral variability is the SNAC absorption window and how much is dose, because the two get conflated constantly?

18 13Dr.LipidDallas, alex_tucson, kevin_tulsa and 15 others
Reply Quote Save Share Report
jason_paloalto
Member
212
890
Nov 2024
Palo Alto, CA
Sep 20, 2025 at 11:26 PM#10

OP back with an update, since a thread like this is useless without one.

Update — I went back to the injectable. Not because the tablet did not work, but because the fasting window and my mornings were never going to agree.

32 7Dr.EndoEP, GraceAZ_72, carl_compliance and 29 others
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register